Antitrust in Pharmaceutical Markets & Geographical Rules of Origin

  • Pierre Kobel
  • Pranvera Këllezi
  • Bruce Kilpatrick

Table of contents

  1. Front Matter
    Pages i-xv
  2. Antitrust in Pharmaceutical Markets

    1. Front Matter
      Pages 1-1
    2. Stephen Dnes
      Pages 3-31
    3. Julie Clarke, Barbora Jedličková
      Pages 33-68
    4. Gerhard Fussenegger, Rainer Schultes
      Pages 69-81
    5. Koen T’Syen
      Pages 83-100
    6. Kamil Nejezchleb
      Pages 101-109
    7. Liliana Eskenazi, Olivier Fréget, Laetitia Ghebali, Clément Hubert, Martina Isola, Nizar Lajnef et al.
      Pages 111-137
    8. Gusztav Bacher, András M. Horváth
      Pages 139-172
    9. Arunabha Ganguli
      Pages 173-179
    10. Elisa Teti, Ottavia Raffaelli
      Pages 181-202
    11. Clement Mifsud-Bonnici
      Pages 203-212
    12. Aleksander Stawicki, Paulina Komorowska, Juliusz Krzyżanowski
      Pages 213-229
    13. Vladimir Bastidas Venegas
      Pages 231-243
    14. Dominique Guex
      Pages 245-261
    15. Cees Jan de Boer, Maria Geilmann
      Pages 263-288
    16. Viktoriia Gladka, Mariia Baranovych
      Pages 289-299
    17. James Bourke
      Pages 301-323
  3. Geographical Rules of Origin

    1. Front Matter
      Pages 325-325
    2. Simon Holzer
      Pages 327-354
    3. Christoph Petsch, Michael Meyenburg
      Pages 355-362
    4. Claire Hazée
      Pages 363-382
    5. Felipe Barros Oquendo
      Pages 383-391
    6. Guillaume Couet, Martina Isola
      Pages 393-416
    7. Olaf Sosnitza
      Pages 417-428
    8. Ádám Liber
      Pages 429-444
    9. Noriko Itai, Kenta Sugimoto, Shigeshi Tanaka
      Pages 445-459
    10. Philip Mifsud, Elise Dingli
      Pages 461-476
    11. Aleksandra Wędrychowska-Karpińska, Agnieszka Wiercińska-Krużewska, Marta Banyk
      Pages 477-497

About this book


This book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property.

The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law.

The second part of the book gathers contributions from various jurisdictions on the topic of “What rules should govern claims by suppliers about the national or geographic origin of their goods or services?” This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things.

The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues.


Pharmaceuticals Competition rules Competition law Consumer protection Geographic origin Drug price regulation

Editors and affiliations

  • Pierre Kobel
    • 1
  • Pranvera Këllezi
    • 2
  • Bruce Kilpatrick
    • 3
  1. 1.Kobel Avocat Attorney-at-lawGenevaSwitzerland
  2. 2.Këllezi LegalGenevaSwitzerland
  3. 3.Addleshaw Goddard LLPLondonUnited Kingdom

Bibliographic information

Industry Sectors